Agertm2.1(cre/ERT2)Blh
Targeted Allele Detail
|
Symbol: |
Agertm2.1(cre/ERT2)Blh |
Name: |
advanced glycosylation end product-specific receptor; targeted mutation 2.1, Brigid L Hogan |
MGI ID: |
MGI:6203633 |
Synonyms: |
Ager-CreERT2 |
Gene: |
Ager Location: Chr17:34816836-34819910 bp, + strand Genetic Position: Chr17, 18.18 cM
|
Alliance: |
Agertm2.1(cre/ERT2)Blh page
|
|
|
Allele Type: |
|
Targeted (Inducible, Null/knockout, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Agertm2.1(cre/ERT2)Blh expression driven by
1 gene
Knock-in expression driven by:
|
|
|
Mutation details: The targeting vector was designed to insert a cre/ERT2 fusion gene, followed by a polyadenylation signal and a frt-flanked neomycin resistance cassette, into the start codon of Ager gene. The construct was electroporated into ES cells for homologous recombination. Correctly targeted ES cells were injected into C57BL/6 blastocysts and resulting chimeric mice were bred with FLP-deleter mice to remove the neo cassette. It is a null allele. Ager protein is not detected in lungs of the homozygous mice.
(J:265836)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Ager
(mouse)
|
|
|
|
|
Original: |
J:265836 Chung MI, et al., Ager-CreER(T2): A New Genetic Tool for Studying Lung Alveolar Development, Homeostasis, and Repair. Am J Respir Cell Mol Biol. 2018 Jul 16; |
All: |
5 reference(s) |
|